Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial.-论文-万方医学网

第一作者： M,Arnedos

第一单位： Department of Cancer Medicine, Breast Cancer Committee, Gustave Roussy, Villejuif, France; INSERM Unit 981, Gustave Roussy, Villejuif, France. Electronic address: monica.arnedos@gustaveroussy.fr.

作者： M,Arnedos ^[1] ; M A,Bayar ^[2] ; B,Cheaib ^[3] ; V,Scott ^[4] ; I,Bouakka ^[4] ; A,Valent ^[5] ; J,Adam ^[6] ; V,Leroux-Kozal ^[5] ; V,Marty ^[7] ; A,Rapinat ^[8] ; C,Mazouni ^[9] ; B,Sarfati ^[9] ; I,Bieche ^[10] ; C,Balleyguier ^[11] ; D,Gentien ^[8] ; S,Delaloge ^[3] ; M,Lacroix-Triki ^[5] ; S,Michiels ^[2] ; F,Andre ^[12]

作者单位： Department of Cancer Medicine, Breast Cancer Committee, Gustave Roussy, Villejuif, France; INSERM Unit 981, Gustave Roussy, Villejuif, France. Electronic address: monica.arnedos@gustaveroussy.fr. ^[1] Statistics and Epidemiology Unit, Gustave Roussy, Villejuif, France; CESP, Medical School, INSERM, Université Paris Saclay, Villejuif, France. ^[2] Department of Cancer Medicine, Breast Cancer Committee, Gustave Roussy, Villejuif, France. ^[3] INSERM Unit 981, Gustave Roussy, Villejuif, France. ^[4] Department of Biology and Pathology, Gustave Roussy, Villejuif, France. ^[5] INSERM Unit 981, Gustave Roussy, Villejuif, France; Department of Biology and Pathology, Gustave Roussy, Villejuif, France. ^[6] Hystopathology and Translational Research Department, Gustave Roussy, Villejuif, France. ^[7] Translational Research Department, Genomics Platform, Institut Curie, PSL Research University, Paris, France. ^[8] Department of Surgery, Gustave Roussy, Villejuif, France. ^[9] Department of Genetics, Institut Curie, Paris, France. ^[10] Department of Radiology, Gustave Roussy, Villejuif, France. ^[11] Department of Cancer Medicine, Breast Cancer Committee, Gustave Roussy, Villejuif, France; INSERM Unit 981, Gustave Roussy, Villejuif, France. ^[12]

医学主题词投药, 口服(Administration, Oral);成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);活组织检查(Biopsy);乳房(Breast);乳腺肿瘤(Breast Neoplasms);细胞增殖(Cell Proliferation);细胞周期蛋白依赖激酶4(Cyclin-Dependent Kinase 4);细胞周期蛋白依赖激酶6(Cyclin-Dependent Kinase 6);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);人类(Humans);Ki-67抗原(Ki-67 Antigen);中年人(Middle Aged);肿瘤辅助疗法(Neoadjuvant Therapy);磷酰化(Phosphorylation);哌嗪类(Piperazines);吡啶类(Pyridines);受体, 雌激素(Receptors, Estrogen);受体, 孕酮(Receptors, Progesterone);视网膜母细胞瘤结合蛋白类(Retinoblastoma Binding Proteins);治疗结果(Treatment Outcome);泛素蛋白连接酶类(Ubiquitin-Protein Ligases)

DOI 10.1093/annonc/mdy202

PMID 29893769

发布时间 2020-04-07

检索历史清除

Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial.

Annals of oncology

相似文献

同项目论文

Annals of oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Modulation of Rb phosphorylation and antiproliferative response to palbociclib: the preoperative-palbociclib (POP) randomized clinical trial.

Annals of oncology

相似文献

同项目论文

Annals of oncology

相关期刊

检索历史清除